Vaccines for Children (VFC) FY26
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) has issued an Award Notice for Vaccines for Children (VFC) FY26. This notice pertains to the provision of Drugs And Biologicals (PSC 6505) for the Vaccines for Children program. The award date is March 27, 2026. Details regarding the specific awardee, contract type, and value are not specified in this notice.
Scope of Work
This award notice is for the Vaccines for Children (VFC) FY26 program, which focuses on ensuring the availability of Drugs And Biologicals (vaccines) for eligible children who might not otherwise be vaccinated due to financial barriers. The program aims to protect children from vaccine-preventable diseases.
Contract & Timeline
- Type: Not specified
- Duration: Not specified
- Value: Not specified
- Set-Aside: None specified
- Award Date: March 27, 2026
- Published: March 27, 2026
Place of Performance
The primary place of performance is indicated as Georgia (GA), United States (30341).
Contact Information
For further inquiries, please contact James Sprigler (zbs6@cdc.gov) or Chad Turner (ukr9@cdc.gov).